Talking with Genesis Communications Network syndicated host Mike Siegel, Merrill Matthews discusses President Trump’s State of the Union pledge to bring down the high cost of prescription drugs, which Matthews says can be done through renegotiating bilateral trade deals. He explains the significant impact intellectual property protections in trade agreements have on U.S. products, including prescription drugs, and also what can further be done in the wake of Obamacare-repeal’s failure to combat the rising cost of healthcare and insurance.
February 7, 2018
Tackling Drug Prices Through Better Trade Deals (Audio: Interview)
2018 02 07 mike siegel matthews drug prices trade intellectual property ip obamacare employer mandate essential benefits